MedTrace Logo

Non-invasive Measures of Distal Lung Disease in Asthmatics

NCT00250341 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2021-12-02

No results posted yet for this study

Summary

This is a Phase 4, single center study conducted in mild-to moderate asthmatics.

Conditions

Interventions

DRUG

QVAR

480 mcg

DRUG

Advair

250/50 mcg

DRUG

Servent Diskus

50 mcg

Sponsors & Collaborators

  • Teva Branded Pharmaceutical Products R&D, Inc.

    lead INDUSTRY

Principal Investigators

  • Michelle Zeidler, MD · University of California, Los Angeles

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-09-30
Primary Completion
2007-09-30
Completion
2007-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00250341 on ClinicalTrials.gov